RAPAFLO
ALLERGAN INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is RAPAFLO discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that RAPAFLO 8MG has been permanently discontinued (last updated November 14, 2022). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is RAPAFLO not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
AURO-SILODOSIN
AURO PHARMA INC
Other Products
SANDOZ SILODOSIN
SANDOZ CANADA INCORPORATED
JAMP SILODOSIN
JAMP PHARMA CORPORATION
SILODOSIN
SANIS HEALTH INC
APO-SILODOSIN
APOTEX INC
PMS-SILODOSIN
PHARMASCIENCE INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02361671
Strength
8MG
Dosage Form
CAPSULE
Route
ORAL
Active Ingredient
SILODOSIN
Tier
Unrated
Last Updated
2022-11-14
Reason for Shortage
Business reasons
Other Products from ALLERGAN INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
2% · DIN 02241407
2.5MG · DIN 02239653
5MG · DIN 02245972
400MG · DIN 01997580
800MG · DIN 02267217
0.5% · DIN 00637661
0.25% · DIN 00751286
400MG · DIN 02083523
DIN 00307246
5MG · DIN 02408163
DIN 00353027
0.03% · DIN 02245860